Reinventing Amlodipine: A Drug Discovery Journey

This lecture is part of the HR NeurotechEU Lectures series. In this session, Prof. Karl Ægir Karlsson (Department of Engineering, Reykjavík University) presents a drug discovery journey exploring the repositioning of amlodipine as a potential treatment for ADHD.

The talk highlights how cross-species models, genetics, and pharmacology were combined to uncover unexpected findings and develop a mechanistic framework supporting translation from bench to human studies.

Register for online participation by 15 April.
The Zoom link will be shared upon registration.